Trials / Completed
CompletedNCT01778465
Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease
Effect of Low Dietary Salicylate on Biochemical Markers of Aspirin Exacerbated Respiratory Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Aspirin-Exacerbated Respiratory Disease, or AERD, consists of aspirin sensitivity, asthma and nasal polyps. It is currently managed by chronic steroid use, multiple endoscopic sinus surgeries and/or aspirin desensitization. However, these treatments have potential adverse effects. A theory has been postulated that decreasing the level of dietary salicylates may help in long-term control of disease. A current trial is in the works to evaluate the clinical outcomes of decreased salicylate, but measurements of biochemical markers of disease has not yet been done. The hypothesis is that decreased dietary salicylates will result in a decrease in urinary salicylates and inflammatory markers of disease, cys-leukotrienes, which are typically elevated in this disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Low salicylate diet | Participants followed a 7 days period under a Low salicylate diet |
| BEHAVIORAL | Normal Diet | Participants followed a 7 days period under a Normal Diet |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-03-01
- Completion
- 2014-05-01
- First posted
- 2013-01-29
- Last updated
- 2021-03-09
- Results posted
- 2021-03-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01778465. Inclusion in this directory is not an endorsement.